We compared the effects on blood pressure (BP) of three isocaloric diets with reduced total fat and saturated fatty acid (SAFA) contents but with different proportions of monounsaturated (MUFA) and polyunsaturated fatty acids (PUFA). Diet LF (low fat) provided 20 en% fat (7.9% SAFA, 7.8% MUFA, 3.0% PUFA); diet HP (high PUFA) 26 en% fat (7.5% SAFA, 8.2% MUFA, 8.1% PUFA), and diet HM (high MUFA) 26 en% fat (7.3% SAFA, 14.1% MUFA, 3.2% PUFA). The diets were consumed for 8 weeks (intervention) preceded by 2 weeks and followed by 8 weeks on a habitual diet (baseline/ switchback) with 33-34 en% fat (13-14% SAFA, 12% MUFA, 6% PUFA). Forty-five free-living couples were randomly allocated into the three diet groups, and 43 men and 44 women completed the study. BP was measured weekly with an automatic device. Compliance to diet was monitored by repeated food records, serum
Introduction
In several animal species dietary fat seems to elevate blood pressure (BP) when the diet is low in salt, 1 but when the salt intake is high, saturated fatty acids (SAFA) tend to increase BP and both n-6 and n-3 polyunsaturated fatty acids (PUFA) to decrease it. 2, 3 In man the effects of dietary fat on BP have been extensively studied, but the results of both observational studies and intervention trials have been conflicting as summarised in several review articles. [4] [5] [6] [7] [8] Total fat intake has not been associated with BP in human cross-sectional studies. [9] [10] [11] [12] [13] [14] [15] In one study 9 an association was found between dietary linoleic acid and low systolic BP (SBP). Dietary SAFA correlated with high BP in two Finnish studies 10, 11 and oleic acid was inversely correlated with BP in two small subject series. 16, 17 An inverse association has been found between BP and linoleic acid in adipose tissue 9, 18, 19 and in serum lipids. 20 In the prospective Nurses' Health Study, dietary fatty acids showed no association with the 4-year incidence of hypertension. 21 An increase in linoleic acid intake has been shown to reduce BP both in combination with reduced fat intake [22] [23] [24] [25] and with unchanged fat intake. [26] [27] [28] [29] In contrast to these findings, several studies have failed to show an effect on BP by increased intake of linoleic acid. 5, [30] [31] [32] [33] In two studies with study periods of 6-8 months, a reduction of BP was observed during a low-fat, high-fibre diet 34 and an American Heart Association Step I diet with moderate fat reduction and equal amounts of SAFA and PUFA. 35 Trials with n-3 fatty acids have indicated that very high intakes of fatty fish and supplementation with fish oil concentrates decrease both SBP and diastolic BP (DBP). [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] In one study both fish oil and corn oil lowered BP in elderly subjects, 47 and another study indicated that linoleic acid might lower BP in individuals with a low intake of n-3 fatty acids. 48 In 1980-1981 three consecutive trials with fatmodified diets were conducted among groups of middle-aged inhabitants of the North Karelia Province in eastern Finland. 24, 25, 29 The results suggested that an increase in the intake of linoleic acid with or without concomitant reduction in total fat intake reduced BP. In view of the conflicting results of other studies we decided to conduct in 1993, in the same area, in people with similar genetic background but with a different background diet, a further study comparing the effects on BP of fatreduced diets including different amounts of linoleic acid and different relationships between MUFA and PUFA. One of the diets mimicked the first dietary intervention from 1980.
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Materials and methods
The subjects were couples, aged 40-65 years, living in the Province of North Karelia in East Finland. They were contacted by advertisements in local newspapers. People who volunteered were screened for hypertension, hypercholesterolaemia and diabetes, and their dietary habits were assessed by a 3-day food record. Exclusion criteria were drug therapy known to affect BP or serum lipids, body mass index (BMI) Ͼ35 kg/m 2 , fasting blood glucose Ͼ6.7 mmol/L, DBP higher than 100 mm Hg and low habitual fat intake (Ͻ30% of energy, en%). An SBP higher than 130 mm Hg and a DBP higher than 80 mm Hg at screening was required for one or both members of each couple. We recruited 45 couples. Three subjects, two men and one woman, dropped out at the beginning of the study, and 87 subjects completed the study.
Study design
The study started with a 2-week baseline period followed by an 8-week intervention period and an 8-week switchback period. During the baseline and the switchback periods the couples were advised to consume their habitual diets. The couples were randomly allocated into three groups of 15 couples each. The groups were similar with respect to age, BMI, serum cholesterol and BP levels at screening (Table 1) . During the intervention period, one group consumed a very low fat diet (LF), the second group a low fat diet relatively rich in PUFA (HP), and the third group a low fat diet relatively rich in MUFA (HM). The subjects were asked to maintain their smoking habits, alcohol consumption and level of physical activity unchanged during the whole 18-week study period. The subjects visited the study centre weekly for weighing and measurement of BP, and for dietary counselling by a nutritionist. There were four nutritionists, each one responsible for the counselling of subjects (couples) from all three groups. The diets were monitored by 3-day food records that were registered every 2nd week throughout the study. The food records were stored in portable computers and processed by the Micro-Nutrica programme (The Social Insurance Institution, Turku, Finland) before the following weekly visit to the nutritionist. The maintenance of stabile body weight and adherence to the prescribed diet were the main goals. During the last 2 weeks of each period the subjects collected on consecutive days three 24-h urine samples, using the Japanese Aliquot cup 49 that collects a standard proportion (1/41.6) of each voided urine specimen into plastic cartridges, also used for storing the samples at −20°C. At the end of each period a fasting venous blood sample was obtained.
Diets
All three intervention diets were low in fat and SAFA but contained different proportions of MUFA and PUFA ( Table 2 ). The diets were designed to contain 8 en% SAFA. For the LF diet the goals were 20 en% total fat and 3 en% PUFA. The HP and HM diets were designed to contain 26 en% fat, the HP diet 8 en% PUFA, and the HM diet 14 en% MUFA. Diet HP was similar to the diet of a previous intervention study conducted in the same area in 1980. 24, 50 The goal for diets LF and HM was to reduce the proportion of PUFA as much as possible but their proportion could not be reduced below 3 en% by using natural foods. In all three diets fatty fish species and foods high in potassium and fibre were restricted in order to reduce differences between the diets in fish-derived n-3 fatty acids and other factors known to affect BP.
The subjects were free-living and purchased their food from local supermarkets. Certain experimental food items (margarine, oil, and salad dressing, manufactured by Unilever Research Laboratorium, Vlaardingen, The Netherlands) with specially designed fatty acid compositions, and some low fat foods like fat-free milk, low fat cheese, and lean meat products were provided free of charge to the participants. To facilitate the adoption of the dietary prescriptions, written advice on fat reduction in cooking and a recipe booklet were given to the subjects in the beginning of the intervention period. Portion sizes for fat-containing foods were given at nine energy levels from 7 to 15 MJ/d for each of the diets. The participants recorded in daily diaries the consumption of the experimental fats, deviations from the prescribed diet, intercurrent illnesses and occasional drug therapy.
Measurement of blood pressure
The BP was measured from the right arm after a 10-min rest in a sitting position. Three recordings were done at 3-min intervals with an automatic device Dinamap TM Vital Signs Monitor Model 1846 SX (Critikon Inc, Tampa, FL, USA) and the mean of the three recordings was calculated. The weekly measurements were done by the same person, on the same weekday, and at the same time of the day. The subjects were blinded for the BP data during the study.
Determinations
The subjects were weighed weekly in light indoor clothing with the same scale. Urinary sodium and potassium were measured using ion-specific electrodes from the samples of the 24-h urine collection stored at −20°C. The fatty acid composition of serum cholesterol esters was determined from a sample stored at −70°C. Lipids were extracted with dichloromethane/methanol, the cholesterol esters were separated by thin-layer chromatography, and the percentual distribution of methylated fatty acids was determined by gas chromatography (HRCG 412, HNU-Nordion Oy, Helsinki, Finland) with a 30 m NB-351 capillary column. Fatty acid peaks from C14:0 to C22:6 were identified by an SC-Workstation (Sunicom Oy, Helsinki, Finland) in a temperatureprogrammed run. The inter-assay CV% for a pooled plasma sample was 1-5% for the major peaks and 5-15% for the minor ones.
Serum and lipoprotein lipids and apolipoproteins were analysed from fresh serum samples. The methods and results are presented elsewhere.
55
Statistical methods
The SBP and DBP values were adjusted for baseline body weight and change of weight. The effects of the diets on the responses and the statistical comparisons between groups and periods were investigated by a repeated measures analysis of covariance using the SAS Mixed Methods software. The results are expressed as least squares means and standard errors (s.e.m.). The results were calculated separately for the whole periods and the last 2 weeks of each period.
Results
The results of the SBP and DBP measurements for the three groups are given in Table 3 and in Figures 1 and 2 . The results are given for men and women combined, because there were no statistically significant between-gender differences. There were no significant changes from the baseline period in SBP or DBP in any of the groups nor any significant differences between the groups. The results were similar for all measurements together and for the last 2 weeks of each period taken separately. On week 4 of the intervention period the BP recordings showed a temporary rise in the LF and the HP groups, and on week 7 of the switchback period the recordings were exceptionally low in all three groups (Figures 1 and 2 ). In the 4th week of intervention the person who regularly performed the BP recordings was replaced by another person which probably explains the increased values.
Of the subjects, 19 had SBP Ͼ150 mm Hg and DBP Ͼ90 mm Hg at the end of the baseline period. They were evenly distributed between the groups. The BP response to the dietary interventions in these individuals was similar to that of the whole group (results not shown). Of the BP readings, 5.8% failed to fall within a range of ±10% for all three recordings. The results were not changed by exclusion of the outlying readings (results not shown).
The average baseline diets of the three groups of subjects comprised 32.8-34.7 en% fat with 13.0-14.7 en% SAFA, 11.4 -12.1 en% MUFA and 5.5-6.3 en% PUFA. During the intervention period the dietary goals were achieved as shown in Table 2 . The proportion of PUFA was reduced to 3.0 en% and 3.2 en% on the LF and HM diets, respectively, and increased to 8.3 en% during the HP diet. The intake of MUFA increased to 14.0 en% on the HM diet and the low fat intake of the LF diet (20.4 en%) was realised. The ratio between dietary polyunsaturated and saturated fatty acids (P/S ratio) of the baseline diets was between 0.39 and 0.49. It was largely unchanged on the LF and HM diets (0.42 and 0.47, respectively) but was increased to 1.15 on the HP diet. According to the repeated food diaries the compositions of the diets remained similar throughout the 8-week intervention period (results not shown). The fatty acid compositions of serum cholesterol esters (Table 4 ) supported the findings from the food records. The proportion of linoleic acid increased significantly on the HP diet and decreased on the LF and HM diets. Oleic acid increased markedly on the HM diet and decreased on the HP diet. The proportions of both palmitic acid and oleic acid showed a small increase on the LF diet. The proportions of the long-chain n-3 fatty acids were similarly reduced on all intervention diets.
The correlations between linoleic acid in serum cholesterol esters and BP were statistically non-significant (r = −0.01, −0.05, and −0.02 for SBP and −0.11, −0.02. and −0.08 for DBP at the end of the baseline, intervention and switchback periods, respectively), and the change in the proportion of linoleic acid during the intervention period showed 386 There was a small but statistically significant reduction in mean body weight during the intervention period in all three groups (Table 5) . During the switchback period no changes in body weight from the intervention period was observed in any of the groups. Sodium excretion increased in the LF and HM groups during the switchback period but there were no differences between the groups in the 24-h urinary excretion of creatinine and sodium ( Table 5 ). The urinary excretion of potassium was significantly higher during the LF diet as compared with the HP and HM diets.
Discussion
In contrast to the three previous dietary trials in North Karelia, no effects on the BP of middle-aged couples by dietary fat modification were observed in the present study. The HP diet of the present study was closely similar to the intervention diet of the 1980 study. 24, 50 The main difference between the two studies is found in the background diets of the subjects constituting the baseline against which the results of the interventions were compared. In 1980 the subjects habitually consumed a diet with 39 en% fat and 3.2 en%, PUFA. In the present study the baseline total fat intake was considerably lower, 33-34 en%, but the proportion of PUFA was higher, about 6 en%. In the early studies PUFA intake was the strongest dietary predictor of BP change. 51 In the present study the increase in the intake of PUFA remained modest because of the relatively high basal intake of the study subjects. On the other hand, the proportion of PUFA was reduced during the LF and HM diets but the study period of 8 weeks might have been too short to induce a significant change in the content of linoleic acid in the tissues, although we found a significant reduction in the proportion of linoleic acid in serum cholesterol esters. In addition, the 1980 diet was higher in salt, and in the experi- mental studies in rats the BP response to dietary fat modification was most evident in animals with low baseline PUFA and high sodium intake. 2, 3 The changes in the background diet between early 1980s and the 1990s in North Karelia have been similar to those found in all parts of Finland. 52 The total fat intake of the population has decreased due to reduced intake of SAFA, and the consumption of PUFA has increased concomitantly. The ageadjusted mortality in coronary heart disease has declined dramatically. This has been mainly the result of decreased serum cholesterol levels but reduced BP levels have contributed to the positive trend. 53 Reduced salt intake and improved pharmacological BP control explain part of the BP decline 53, 54 but an additional effect by increased consumption of PUFA cannot be overruled.
The study population was normotensive with mean BP levels comparable with those of the previous studies. 24, 25, 29 We excluded hypertensive individuals and those with low BP levels unless the spouse fulfilled the criteria for recruitment. At screening a large proportion of the participants were borderline hypertensive, but both SBP and DBP levels showed a tendency to decline after screening and during the baseline period. The effects of sodium and potassium intake may be different in hypertensive and normotensive subjects 6 but in the previous studies the effect on BP of fat modification was only partially dependent on initial BP levels. 24, 25, 29 Furthermore, the results of the 19 mildly hypertensive subjects of our study did not differ from those of the rest of the study population. Both the increase in the 24-h urinary excretion of sodium during the switchback period, especially in the HM group, and the sharp changes in BP during the last 2 weeks of the study were apparently consequences of an unusual heatwave that coincided with a national holiday. Based on the food records, the subjects consumed more sausages, beer and soft drinks during the switchback period. These are common habits for Finns in summertime.
It is possible that the effect on BP of linoleic acid is dependent on the level of PUFA and the P/S ratio of the background diet. In all previous studies that showed an effect on BP the initial P/S ratios were below 0.3, whereas in the studies that showed no effect the P/S ratios ranged between 0.3 and 0.55. The double-blind trials with linoleic acid that did not show an effect have been carried out in populations where the initial diet already included an adequate level of linoleic acid. 6 However, there are two recent studies with somewhat different findings. In a controlled, 8-month trial of a low-fat, high-fibre diet among healthy normotensive subjects a change in total fat intake from 37 en% to 26 en% together with a change in SAFA intake from 14 en% to 8 en% and PUFA intake from 5 en% to 6 en% (P/S ratio from 0.39 to 0.75) reduced SBP significantly in men. 34 The effect appeared first after 3 months intervention, and there were other dietary changes such as a reduced Na/K ratio, reduced alcohol consump-tion, and increased fibre intake (from 30 to 50 g per day) that could explain the effect. In another longterm study 35 a diet high in PUFA (10 en%) reduced SBP in men during a 6-month trial compared with a baseline diet with 4 en% PUFA and a P/S ratio of 0.29.
In conclusion, neither reduction in total fat intake nor roughly halving or doubling the intake of PUFA from the background level of 5.5-6 en% affected the BP of middle-aged subjects from North Karelia. This result, together with the findings from previous studies, suggests that the effect of dietary fat modification on BP may depend on the baseline PUFA intake. At very low intakes increased consumption of PUFA may reduce BP but at normal PUFA intakes no further effect on BP can be achieved.
